In this regard, the American Society of Clinical Oncology recommends that all women diagnosed with epithelial ovarian cancer undergo germline genetic testing, especially to detect BRCA1/2 and other genes related to ovarian cancer susceptibility. This evidence concerns the gene BRCA1 and ovarian cancer.